5.10% p.a. Early Redemption Worst of GOAL

Underlying: Biogen Idec / Novo Nordisk / Shire SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 41051278 / ISIN: CH0410512781

Last update 16.07.2018
  • Bid

    100.57 %
    Volume: 10'000

  • Ask

    101.57 %
    Volume: 10'000

CurrencyEUR
IssuerUBS AG, London Branch
Settlementphysical
Issue date09.04.2018
Expiry14.04.2020
Sideways return-- / --
Unit price1'000.00 EUR
Underlying price1)
Biogen Idec
Novo Nordisk
Shire

353.03 USD
-- DKK
-- GBP
Display
  • Product chart
1) Prices are 15 Min. delayed